Forte Biosciences Statistics

Total Valuation

FBRX has a market cap or net worth of $93.98 million. The enterprise value is $77.62 million.

Market Cap	93.98M
Enterprise Value	77.62M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

FBRX has 6.39 million shares outstanding. The number of shares has increased by 82.51% in one year.

Current Share Class	6.39M
Shares Outstanding	6.39M
Shares Change (YoY)	+82.51%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	8.82%
Owned by Institutions (%)	41.36%
Float	4.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.29
P/TBV Ratio	10.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.06

Current Ratio	2.06
Quick Ratio	1.91
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -137.40% and return on invested capital (ROIC) is -89.48%.

Return on Equity (ROE)	-137.40%
Return on Assets (ROA)	-67.66%
Return on Capital (ROIC)	-89.48%
Revenue Per Employee	n/a
Profits Per Employee	-$3.80M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.61% in the last 52 weeks. The beta is 2.83, so FBRX's price volatility has been higher than the market average.

Beta (5Y)	2.83
52-Week Price Change	-15.61%
50-Day Moving Average	17.24
200-Day Moving Average	13.04
Relative Strength Index (RSI)	39.02
Average Volume (20 Days)	61,200

Short Selling Information

The latest short interest is 342,850, so 5.36% of the outstanding shares have been sold short.

Short Interest	342,850
Short Previous Month	285,948
Short % of Shares Out	5.36%
Short % of Float	8.15%
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.63M
Pretax Income	-32.14M
Net Income	-34.20M
EBITDA	-35.60M
EBIT	-35.63M
Earnings Per Share (EPS)	-$18.53

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	16.36M
Total Debt	n/a
Net Cash	16.36M
Net Cash Per Share	$2.56
Equity (Book Value)	9.37M
Book Value Per Share	6.42
Working Capital	9.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.71 million and capital expenditures -$23,000, giving a free cash flow of -$29.73 million.

Operating Cash Flow	-29.71M
Capital Expenditures	-23,000
Free Cash Flow	-29.73M
FCF Per Share	-$4.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-82.51%
Shareholder Yield	-82.51%
Earnings Yield	-36.38%
FCF Yield	-31.63%

Analyst Forecast

The average price target for FBRX is $77.58, which is 427.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$77.58
Price Target Difference	427.76%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.81%

Stock Forecasts

Stock Splits

The last stock split was on August 28, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Aug 28, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1